Kline & Specter, PC v. Haviland, D.

Superior Court of Pennsylvania·Decided October 22, 2014·No. 3206 EDA 2013·Unpublished

Opinion

NON-PRECEDENTIAL DECISION - SEE SUPERIOR COURT I.O.P. 65.37

KLINE & SPECTER, P.C., : IN THE SUPERIOR COURT OF : PENNSYLVANIA Appellee :

:

v. :

:

DONALD E. HAVILAND, JR., :

:

Appellant : No. 3206 EDA 2013

Appeal from the Order entered on August 7, 2013 in the Court of Common Pleas of Philadelphia County, Civil Division, No. 1922 July Term 2007

BEFORE: FORD ELLIOTT, P.J.E., MUNDY and MUSMANNO, JJ. MEMORANDUM BY MUSMANNO, J.: FILED OCTOBER 22, 2014 Donald E. Haviland, Jr. (“Haviland”) appeals from the Order confirming the arbitration panel’s Decision and Award dated March 4, 2013, and entering Judgment against him in the amount of $210,220.95 plus 6% annual interest. We reverse.

Haviland, an attorney practicing in this Commonwealth, was hired by Kline & Specter, P.C. (“K&S”), in 2001 to manage a newly-formed “Class Action Department” at the law firm. Haviland’s Employment Agreement set forth the terms that would control the apportionment of client fees and cost- sharing in the event Haviland left K&S. In particular, Paragraph 5 of the Employment Agreement (“Employment Agreement”) provided that Haviland must pay K&S a “referral fee” comprised of one-third of the gross amount of client fees he received for any non-class action matter in which he continued

to act as counsel after parting with K&S. Employment Agreement, ¶ 5. Paragraph 10 of the Employment Agreement provided that the parties agreed to enforce the Employment Agreement “by either binding arbitration under [Pennsylvania’s] Arbitration Act of 1927 [“1927 Act”1] or through court action, at the option of K&S.” Id., ¶ 10 (footnote added).

While employed at K&S, Haviland assumed K&S’s representation of the Commonwealth of Pennsylvania (“Commonwealth”) in more than a dozen lawsuits involving major brand-name prescription drug companies. The litigation was referred to as Pennsylvania Average Wholesale Price (hereinafter, “PA-AWP”). Haviland also worked for K&S on similar litigation known as Lupron Blues. Haviland left K&S in 2006, and it was agreed that he would continue to act as counsel for the Commonwealth in the PA-AWP and Lupron Blues cases, as K&S was closing its Class Action Department. Six months later, Haviland’s new law firm2 secured the Commonwealth’s first favorable settlement with a defendant in PA-AWP.

1 The 1927 Act originally was codified at 5 P.S. § 161 et seq. However, the 1927 Act subsequently was repealed and replaced by the Pennsylvania Uniform Arbitration Act of 1980 (“1980 Act”). See 42 Pa.C.S.A. §§ 7301- 7320. Despite the fact that the 1927 Act has been repealed, “parties remain free to agree to proceed according to the 1927 Act.” See Pantellis v. Erie Ins. Exch., 890 A.2d 1063, 1065 (Pa. Super. 2006); Nationwide Mut. Ins. Co. v. Heintz, 804 A.2d 1209, 1214 (Pa. Super. 2002); see also Geisler v. Motorists Mut. Ins. Co., 556 A.2d 391, 393 (Pa. Super. 1989) (stating that arbitration conducted under the provisions of the 1927 Act constitutes a statutory arbitration). 2 Upon leaving K&S, Haviland established his own firm, Haviland Hughes, LLC (“Haviland Hughes”).

On July 13, 2007, K&S filed a Petition for the Appointment of an Arbitration to appoint arbitrators to adjudicate its claims under the Employment Agreement, primarily the allocation of fees that Haviland received, and would receive, in PA-AWP. K&S argued that Paragraph 5 of the Employment Agreement obligated Haviland to pay K&S one-third of the gross fees he received from the settlements and potential verdicts involving PA-AWP and Lupron Blues. The matter initially proceeded to mediation, which failed. Thereafter, the trial court ordered arbitration to proceed before three arbitrators, one selected by each party, and the third selected by the named arbitrators.

After the three arbitrators were selected, numerous hearings were held between October 12, 2009, and April 5, 2011, pursuant to the 1927 Act. On May 18, 2011, two of the three arbitrators (“the panel”) agreed to give K&S a partial award on its claim for a one-third “referral fee.”3 The panel ordered Haviland to pay approximately $1.9 million, plus interest from the date the fees were received, to K&S.4 In addition, Haviland was ordered to pay one- third, plus interest, of any fees he realized in future settlements involving

3 K&S originally argued that it should be paid one-third of the gross fees received by all of the law firms (7 total) involved in PA-AWP, not just the fees received by Haviland. The arbitration panel awarded K&S one-third of the gross fees received by Haviland only. All other claims were denied, including the claims against Haviland Hughes. 4 The cases included in this award included Lupron Blues, PA-AWP–Glaxo Smith Kline (“GSK”), PA-AWP–Abbott, PA-AWP–Baxter, PA-AWP– AstraZeneca, PA-AWP–TAP Pharmaceutical, and PA-AWP–Dey.

PA-AWP. The third arbitrator, retired Judge Joseph Del Sole, disagreed with the panel’s award, and opined that K&S was not entitled to a referral fee in PA-AWP or Lupron Blues.5 Both K&S and Haviland filed Petitions to Vacate, Correct, or Modify the arbitration award. However, while these Petitions were pending, the Commonwealth reached settlements with PA-AWP—Aventis; PA-AWP— Bayer; PA-AWP—Pharmacia and Pfizer; and PA-AWP—Schering Plough (collectively “the Aventis settlement”).6 As part of this settlement, the Commonwealth Court of Pennsylvania entered an Order awarding Haviland $8,621,037.64 in fees. Thereafter, on September 20, 2011, the parties agreed to enter into a Stipulation to Confirm Arbitration Award and Enter Judgment (“Stipulation”). As part of the Stipulation, Haviland agreed to pay K&S $327,014.23 for the Lupron Blues settlement and $5,412,475.92 for the

5 Judge Del Sole did not believe that Paragraph 5 of the Employment Agreement applied to PA-AWP or Lupron Blues, as he considered that litigation to constitute class-action matters, and Paragraph 5 only pertained to “non-class matters.” 6 The only claims remaining following the Aventis settlement involved PA- AWP—Johnson & Johnson and PA-AWP—Bristol Meyers Squibb. On August 31, 2011, the Commonwealth Court entered judgment in favor of the Commonwealth and against Bristol Meyers Squibb in the amount of $27,715,904. See Commonwealth v. TAP Pharm. Prods., Inc., 36 A.3d 1197, 1295 (Pa. Cmwlth. 2011). On that same date, the Commonwealth Court entered judgment in favor of the Commonwealth and against Johnson & Johnson. See Commonwealth v. TAP Pharm. Prods., Inc., 36 A.3d 1112, 1190 (Pa. Cmwlth. 2011). On June 16, 2014, the Supreme Court of Pennsylvania vacated the Commonwealth Court’s Orders and remanded for further proceedings. See Commonwealth v. TAP Pharm. Prods., Inc., 94 A.3d 350, 363-64 (Pa. 2014); Commonwealth v. TAP Pharm. Prods., Inc., 94 A.3d 364, 366 (Pa. 2014).

PA-AWP settlement, and the parties agreed to withdraw their Petitions to Vacate, Correct, or Modify the arbitration award. On October 3, 2011, the trial court entered the Stipulation as an Order of court and entered Judgment in favor of K&S in the amount of $5,739,490.15.

Free access — add to your briefcase to read the full text and ask questions with AI

Kline & Specter, PC v. Haviland, D., (Pa. Ct. App. 2014).

Kline & Specter, PC v. Haviland, D. (Kline & Specter, PC v. Haviland, D.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Pantelis v. Erie Insurance Exchange
890 A.2d 1063 (Superior Court of Pennsylvania, 2006)
Nationwide Insurance v. Calhoun
635 A.2d 643 (Superior Court of Pennsylvania, 1993)
Seay v. Prudential Property & Casualty Insurance
543 A.2d 1166 (Superior Court of Pennsylvania, 1988)
Geisler v. Motorists Mutual Insurance
556 A.2d 391 (Supreme Court of Pennsylvania, 1989)
Nationwide Mutual Insurance v. Heintz
804 A.2d 1209 (Superior Court of Pennsylvania, 2002)
Key Automotive Equipment Specialists, Inc. v. Abernethy
636 A.2d 1126 (Superior Court of Pennsylvania, 1994)
PNC Bank, N.A. v. Unknown Heirs
929 A.2d 219 (Superior Court of Pennsylvania, 2007)
DUNLAP BY HOFFMAN v. State Farm Ins.
546 A.2d 1209 (Supreme Court of Pennsylvania, 1988)
Gargano v. Terminix International Co.
784 A.2d 188 (Superior Court of Pennsylvania, 2001)
Commonwealth v. Tap Pharmaceutical Products, Inc.
36 A.3d 1197 (Commonwealth Court of Pennsylvania, 2011)
Joseph v. Advest, Inc.
906 A.2d 1205 (Superior Court of Pennsylvania, 2006)
U.S. Claims, Inc. v. Dougherty
914 A.2d 874 (Superior Court of Pennsylvania, 2006)
Maxton v. Philadelphia Housing Authority
454 A.2d 618 (Superior Court of Pennsylvania, 1982)
Shelly Enterprises, Inc. v. Guadagnini
20 A.3d 491 (Superior Court of Pennsylvania, 2011)
Burke v. Erie Insurance Exchange
940 A.2d 472 (Superior Court of Pennsylvania, 2007)
Commonwealth v. Tap Pharmaceutical Products, Inc.
36 A.3d 1112 (Commonwealth Court of Pennsylvania, 2011)
Milliken v. Jacono
60 A.3d 133 (Superior Court of Pennsylvania, 2012)
Knight v. Springfield Hyundai
81 A.3d 940 (Superior Court of Pennsylvania, 2013)
Commonwealth v. TAP Pharmaceutical Products, Inc.
94 A.3d 350 (Supreme Court of Pennsylvania, 2014)
Commonwealth v. Tap Pharmaceutical Products, Inc.
94 A.3d 364 (Supreme Court of Pennsylvania, 2014)